Cargando…
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program
The Society for Immunotherapy of Cancer, SITC (formerly the International Society for Biological Therapy of Cancer, iSBTc), aims to improve cancer patient outcomes by advancing the science, development and application of biological therapy and immunotherapy. The society and its educational programs...
Autores principales: | Balwit, James M, Hwu, Patrick, Urba, Walter J, Marincola, Francesco M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038923/ https://www.ncbi.nlm.nih.gov/pubmed/21281484 http://dx.doi.org/10.1186/1479-5876-9-18 |
Ejemplares similares
-
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010) -
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
por: Bedognetti, Davide, et al.
Publicado: (2011) -
Announcing the Tumor Immunology and Biological Cancer Therapy section (edited by iSBTc) of the Journal of Translational Medicine
por: Romero, Pedro, et al.
Publicado: (2009) -
A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
por: Butterfield, Lisa H, et al.
Publicado: (2008) -
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
por: Raval, Raju R, et al.
Publicado: (2014)